Literature DB >> 7890492

Quantification of cystoid changes in diabetic maculopathy.

O Arend1, A Remky, A E Elsner, B Bertram, M Reim, S Wolf.   

Abstract

PURPOSE: In patients with diabetic macular edema and cysts, quantification of the extent of the cystoid formation has been difficult. This study was performed to introduce reliable measurements of cysts, the quantification of the extent, and its relation to visual acuity.
METHODS: Fluorescein angiography generated with a scanning laser ophthalmoscope provided detailed recognition not only of the foveal microvasculature, but also of well-demarcated cystoid formations in the early phases. The sampling area included the central 2.5 degrees of the fovea. Using digital image analysis, two independent observers estimated the area covered by cysts, the number of cysts, and the foveal avascular zone (FAZ).
RESULTS: Twenty-three subjects with diabetes and macular cysts were enrolled in the current study. The mean area of the cysts was 0.315 +/- 0.241 mm2 (0.05 mm2 to 0.9 mm2), and the number of cysts ranged from 1 to 7. Both parameters, area of cysts (r2 = 0.61), and number of cysts (r2 = 0.48) showed a significant correlation with visual acuity (P < 0.01), whereas FAZ (0.08 to 0.58 mm2) showed no significant correlation with visual acuity.
CONCLUSIONS: Fluorescein angiography allows a reproducible quantification of the extent of macular cysts. The relation of visual acuity to the number of cysts and to the area covered by the cystoid formation is highly significant. Thus, both these measures can provide an objective criterion for the estimation of visual prognosis and an outcome for evaluation therapy techniques.

Entities:  

Mesh:

Year:  1995        PMID: 7890492

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  8 in total

1.  Improved contrast of subretinal structures using polarization analysis.

Authors:  Stephen A Burns; Ann E Elsner; Mariane B Mellem-Kairala; Ruthanne B Simmons
Journal:  Invest Ophthalmol Vis Sci       Date:  2003-09       Impact factor: 4.799

2.  Quantitative assessment of macular thickness in normal subjects and patients with diabetic retinopathy by scanning retinal thickness analyser.

Authors:  Y Oshima; K Emi; S Yamanishi; M Motokura
Journal:  Br J Ophthalmol       Date:  1999-01       Impact factor: 4.638

3.  A new colour vision arrangement test to detect functional changes in diabetic macular oedema.

Authors:  N Maár; M Tittl; M Stur; B Zajic; A Reitner
Journal:  Br J Ophthalmol       Date:  2001-01       Impact factor: 4.638

4.  Subtle changes in diabetic retinas localised in 3D using OCT.

Authors:  Edmund Arthur; Joel A Papay; Bryan P Haggerty; Christopher A Clark; Ann E Elsner
Journal:  Ophthalmic Physiol Opt       Date:  2018-07-26       Impact factor: 3.117

5.  Reproducibility of volumetric macular measurements in diabetic patients with the Heidelberg Retina Tomograph.

Authors:  H J Zambarakji; S A Vernon; A F Spencer; W M Amoaku
Journal:  Doc Ophthalmol       Date:  1999       Impact factor: 2.379

6.  Central Macular Thickness in Diabetic Patients: A Sex-based Analysis.

Authors:  Edmund Arthur; Stuart B Young; Ann E Elsner; Karthikeyan Baskaran; Joel A Papay; Matthew S Muller; Thomas J Gast; Bryan P Haggerty; Christopher A Clark; Victor E Malinovsky; Shane G Brahm; Taras V Litvin; Glen Y Ozawa; Jorge A Cuadros
Journal:  Optom Vis Sci       Date:  2019-04       Impact factor: 1.973

7.  Reproducibility of volumetric measurements of normal maculae with the Heidelberg retina tomograph.

Authors:  H J Zambarakji; J E Evans; W M Amoaku; S A Vernon
Journal:  Br J Ophthalmol       Date:  1998-08       Impact factor: 4.638

8.  Comparison of Cysts in Red and Green Images for Diabetic Macular Edema.

Authors:  Mastour A Alhamami; Ann E Elsner; Victor E Malinovsky; Christopher A Clark; Bryan P Haggerty; Glen Y Ozawa; Jorge A Cuadros; Karthikeyan Baskaran; Thomas J Gast; Taras V Litvin; Matthew S Muller; Shane G Brahm; Stuart B Young; Masahiro Miura
Journal:  Optom Vis Sci       Date:  2017-02       Impact factor: 1.973

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.